Macro Biologics
PrivateLast Round
Grant
Dec 16, 2025
Total Funding Raised
$23.57M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Macro Biologics operates in Healthcare & Life Sciences and is based in Carlsbad, California. Its latest recorded funding round was a Grant round in December 2025.
Macro Biologics is a biotechnology company that develops synthetic biological polymers for breakthrough therapeutics, next-generation medical devices, and advanced biomaterials.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Advanced Materials, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Macro Biologics Comparables
Compare Macro Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Prevent-Plus, LLC | 82% | |
| Sonoran Biosciences | 82% | |
| KeriCure Medical | 81% |
For institutional investors. Book with your work email.
Macro Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 16, 2025 | ||||
| Series A | Sep 4, 2024 | ||||
| Grant | Aug 14, 2023 | ||||
| Early Funding | Aug 14, 2023 | ||||
| Grant | Jun 22, 2020 | ||||
Convertible Debt | Feb 12, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Macro Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Novo Nordisk Foundation | Grant |
| CARB-X | Grant |
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
| U.S. Department of War | Grant |
| Oscar & Paul Beiersdorf Venture Capital | Series A |
| Impact Foundation | Early Funding, Grant |
| Wellcome Trust | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 36% MoM.
- May 16, 2026
Monthly visitors grew 117% MoM.
For institutional investors. Book with your work email.
Macro Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Macro Biologics's valuation, stock price, and market status.
Is Macro Biologics a public or private company?
Macro Biologics is a private company.
What is the current stock price of Macro Biologics?
Macro Biologics is a private company, so its shares have no public market price. Caplight tracks Macro Biologics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Macro Biologics worth (valuation)?
Valuation information for Macro Biologics is not publicly available.
Can I buy Macro Biologics stock?
Macro Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Macro Biologics's last funding round?
Macro Biologics's most recent funding round was Grant on December 16, 2025.
Who are the main investors in Macro Biologics?
Key investors in Macro Biologics include CARB-X, U.S. Department of War, Impact Foundation.
Will Macro Biologics IPO soon?
No public IPO plans have been announced for Macro Biologics.
How can I track Macro Biologics secondary market activity?
Caplight tracks bids, offers, and trades in Macro Biologics's shares on secondary markets.